Suspension of trading
Centessa Pharmaceuticals plc Stock
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.48B 5.03B 4.7B 8.9B 597B 9.03B 60.44B 23.49B 293B 23.53B 23.01B 1,011B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.33B 4.89B 4.56B 8.65B 580B 8.78B 58.74B 22.83B 285B 22.87B 22.37B 983B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 1 month | +1.63% | ||
| 3 months | +2.04% | ||
| 6 months | +70.96% | ||
| Current year | +61.94% |
| 1 month | 39.58 |  | 40.56 |
| Current year | 21.5 | | 40.56 |
| 1 year | 13.22 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-24 | Issuer sale | Chief Technology Officer | -1,085,687 | 0.7017% | ||
| 06-24 | Issuer sale | Executive/Senior Manager | -1,578,908 | 1.0204% | ||
| 06-24 | Issuer sale | Chief Executive Officer | -809,707 | 0.5233% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +187.85% | +569.42% | 6.27B | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +11.89% | +38.86% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +13.67% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +2.04% | +5.43% | +91.91% | +170.20% | 25.19B | |
| Weighted average by Cap. | +2.04% | +6.42% | +93.34% | +149.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.12 12.04 11.24 21.3 1.43K 21.61 144.66 56.23 701.3 56.32 55.09 2.42K |
| Net income | -236M -206M -189M -177M -335M -22.44B -340M -2.27B -884M -11.02B -885M -866M -38.04B | -198M -173M -159M -148M -280M -18.81B -285M -1.91B -740M -9.24B -742M -725M -31.87B |
| Net Debt | -364M -319M -292M -273M -517M -34.69B -525M -3.51B -1.37B -17.03B -1.37B -1.34B -58.78B | -176M -154M -141M -132M -250M -16.77B -254M -1.7B -660M -8.24B -662M -647M -28.43B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
